Literature DB >> 7693968

Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication.

A H Lund1, M Duch, J Lovmand, P Jørgensen, F S Pedersen.   

Abstract

Two Akv murine leukemia virus-based retroviral vectors with primer binding sites matching tRNA(Gln-1) and tRNA(Lys-3) were constructed. The transduction efficiency of these mutated vectors was found to be comparable to that of a vector carrying the wild-type primer binding site matching tRNA(Pro). Polymerase chain reaction amplification and sequence analysis of transduced proviruses confirmed the transfer of vectors with mutated primer binding sites and further showed that tRNA(Gln-2) may act efficiently in conjunction with the tRNA(Gln-1) primer binding site. We conclude that murine leukemia virus can replicate by using various tRNA molecules as primers and propose primer binding site-tRNA primer interactions to be of major importance for tRNA primer selection. However, efficient primer selection does not require perfect Watson-Crick base pairing at all 18 positions of the primer binding site.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693968      PMCID: PMC238174     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Reverse transcriptase mediated binding of primer tRNA to the viral genome.

Authors:  A Araya; L Sarih; S Litvak
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

2.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

4.  Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5.

Authors:  E Beck; G Ludwig; E A Auerswald; B Reiss; H Schaller
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

5.  Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene.

Authors:  J E Majors; H E Varmus
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

6.  A detailed model of reverse transcription and tests of crucial aspects.

Authors:  E Gilboa; S W Mitra; S Goff; D Baltimore
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

7.  Reverse transcriptase as the major determinant for selective packaging of tRNA's into Avian sarcoma virus particles.

Authors:  G G Peters; J Hu
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

8.  A novel sequence segment and other nucleotide structural features in the long terminal repeat of a BALB/c mouse genomic leukemia virus-related DNA clone.

Authors:  C Y Ou; L R Boone; W K Yang
Journal:  Nucleic Acids Res       Date:  1983-08-25       Impact factor: 16.971

9.  Binding of tRNA to reverse transcriptase of RNA tumor viruses.

Authors:  A Panet; H Berliner
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

10.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  28 in total

1.  Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.

Authors:  A H Lund; M Duch; F S Pedersen
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4.

Authors:  C Modin; F S Pedersen; M Duch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Complementarity-directed RNA dimer-linkage promotes retroviral recombination in vivo.

Authors:  Jacob Giehm Mikkelsen; Søren Vestergaard Rasmussen; Finn Skou Pedersen
Journal:  Nucleic Acids Res       Date:  2004-01-09       Impact factor: 16.971

4.  The primer binding site on the RNA genome of human and simian immunodeficiency viruses is flanked by an upstream hairpin structure.

Authors:  B Berkhout
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

5.  Multiple molecular determinants for retrotransposition in a primer tRNA.

Authors:  J B Keeney; K B Chapman; V Lauermann; D F Voytas; S U Aström; U von Pawel-Rammingen; A Byström; J D Boeke
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

6.  Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.

Authors:  X Li; J Mak; E J Arts; Z Gu; L Kleiman; M A Wainberg; M A Parniak
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region.

Authors:  J G Mikkelsen; A H Lund; M Duch; F S Pedersen
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Impact of forced selection of tRNAs on HIV-1 replication and genome stability highlight preferences for selection of certain tRNAs.

Authors:  Na Ni; Casey D Morrow
Journal:  Virus Res       Date:  2006-10-30       Impact factor: 3.303

9.  Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.

Authors:  J M Whitcomb; B A Ortiz-Conde; S H Hughes
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.